Company Overview

Update
Closed:
Closed, Date Unknown
Headquarters:
Boston, MA
Funding:
$23.3M
Categories:
Biotechnology
Description:
SpringLeaf Therapeutics develops drug delivery technologies.

Detailed Description

Update

SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on convergent science and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Flybridge Capital Partners and North Bridge Venture Partners.

Past Team (2)

Update

Funding Rounds (2) - $23.3M

Update

Board Members and Advisors (1)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    8 St. Mary's Street

    Suite 601

    Boston, MA 02215

    USA

Images (1)

Update
  • 3faf39f732e6cd0e16f53b1b697d3220